Protalix BioTherapeutics, Inc. (AMEX:PLX) Quarterly EPS Analysis

The shares went up by 0.26% in value last month.

Protalix BioTherapeutics, Inc. (PLX) has the market capitalization of $110.68 Million. That compares with the recent volume average of 990.24 million. The Company is focused on the development and commercialization of recombinant therapeutic proteins based on its ProCellEx protein expression system (ProCellEx). Oral Anti-TNF represents a mode of administering a recombinant anti-TNF protein. Protalix's first product manufactured by ProCellEx, taliglucerase alfa, was approved for marketing by the U.S. Food and Drug Administration (FDA) in May 2012 and, subsequently, by the regulatory authorities of other countries. OxFORD Asset Management LLP owned approximately 0.54% of Protalix Biotherapeutics as of its most recent SEC filing.

Protalix BioTherapeutics, Inc. (NYSE:PLX) received a Buy rating from 1 analysts. The share price has already crossed its 20 days moving average, floating at a distance of 2.31% and sits 0.49% higher versus its 50 days moving average. 0 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. The stock touched 52-week High of $1.51 on 03/14/17 and 52-week Low of $0.26 on 12/13/16. This shows a surprise factor of 0.3%. The same analysts are predicting that the company shares will trade to $3.40 within the next 12-18 months. The firm had revenue of $6.36 million for the quarter, compared to analyst estimates of $5.05 million. The industry's and sector's high P/E for the past year is 134.49 and 31.67 respectively and low P/E ratio for the last 5 years is 5.82 for the industry and 10.03 for the Sector.

Analysts are also projecting an Average Revenue Estimate for Protalix BioTherapeutics, $6650 in the Current Quarter. They see Protalix BioTherapeutics, Inc.

Looking into last 5 trades, the stock observed a return of nearly 41.64%. For the long-term approach of trading or also can for short period of time, 200 days MA can also help to get idea about trading, PLX has -19.40% which indicates Bearish trends and this can also make isolating trends easier. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders. The return on assets stands at 0%, Return on Equity now is 0% and the Return on Investment value is 0%.

07/15/2014 - Protalix BioTherapeutics, Inc. was upgraded to "neutral" by analysts at Zacks. The stock is now moving above its 20-Day Simple Moving Average of 28.08% with a 50-Day Simple Moving Average of 33.81 percent.

Let's take a look at how the stock has been performing recently.

The company's stock is now moving with a -ve distance from the 200 day SMA of approximately -4.12%, and has a solid year to date (YTD) performance of 75.51% which means that the stock is constantly adding to its value from the previous fiscal year end price.

Like this


21 October 2017
Walgreens Boots Alliance, Inc. (WBA) Stock Rating Lowered by Zacks Investment Research
The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website . The Firm operates through three divisions: Retail Pharmacy USA , Retail Pharmacy International and Pharmaceutical Wholesale.

21 October 2017
Irish Rail Workers Reveal Dates For Strike Action
The strikes, which will include picketing by union members, are over pay disputes with Iarnrod Eireann management. We should know by this afternoon whether there'll be a strike at Irish Rail before Christmas.

21 October 2017
Morgan Stanley Raises Progressive Corporation (The) (PGR) Price Target to $51.00
Artisan Partners Limited Partnership lifted its stake in shares of Progressive Corporation (The) by 40.4% in the second quarter. Progressive Corporation (The) (NYSE:PGR) last released its quarterly earnings data on Tuesday, October 17th.

21 October 2017
Taylor Morrison Home Corporatio (NYSE:TMHC) Experiences Light Trading Volume
Brandywine Global Investment Limited Liability Company invested 0.03% of its portfolio in Taylor Morrison Home Corp (NYSE:TMHC). This buyback authorization allows the construction company to purchase up to 2.9% of its stock through open market purchases.

20 October 2017
Braid-chopping: 'Mentally-challenged' man, another person rescued from mob in JK
Social media is being used to spread "braid chopping" rumours in Jammu and Kashmir which is resulting attacks on innocent men. The victims have said that unknown assailants cut their hair after knocking them unconscious with some spray.

20 October 2017
Huge TLC Changes: Kurt Angle Returns! Styles Vs. Balor!
On Friday, it was revealed that Angle will be replacing Roman Reigns at the upcoming WWE TLC: Tables, Ladders and Chairs event. This will be Angle's first match in a WWE ring in more than 11 years when he lost to Randy Orton at Vengeance 2006.

20 October 2017
Indian American Girl Named America's Top Young Scientist
Rao plans to save some of the prize money for college but use the rest to invest in her device to make it commercially viable. The device developed by Rao is a sensor that can detect lead in water faster than other current techniques.

20 October 2017
Yum! Brands, Inc. (YUM) Price Target Raised to $78.00 at Barclays PLC
The stock of Yum! Brands from $66.00 to $77.00 and gave the company a "market perform" rating in a report on Thursday, August 3rd. The restaurant operator reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.61 by $0.07.

20 October 2017
Trump's new travel ban blocked, challenged for discrimination, violation of Constitution
French wrote that the judges' "job is to assess whether a policy is constitutional, not whether it's prudent or wise". Here's the Supreme Court: The interest in preserving national security is "an urgent objective of the highest order".

20 October 2017
Looking for work? Prince William, Prince Harry and Duchess Kate are hiring!
In the listing for the job, the palace did include the duties of press briefings and handling special projects. The Duke and Duchess of Cambridge and Prince Harry are hiring a senior communications officer.